Sansure Biotech Inc.

Sansure Biotech Inc., a listed company in China, is a comprehensive provider of integrated diagnosis and treatment solutions, with independent and innovative gene technology at its core. Founded in 2008, with Changsha and Shanghai as its strategic hubs, Sansure has further expanded its global presence and established more than 40 subsidiaries and branches across China and key global markets including the UK, France, the US, Indonesia, the Philippines, Thailand, and beyond. With over 40% of employees dedicated to R&D, the company has pioneered a series of leading core technologies and developed over 1,000 products, along with more than 2,200 kinds of high-quality testing services, covering reagent, instrument, quality control, technical training and service, independent clinical laboratory service, genetic testing service, biopharmaceutical, etc. These products and solutions are used by over 10,000 benchmark hospitals and laboratories worldwide, serving billions of people across over 160 countries and regions. With unwavering determination, Sansure will continue to advance its transformation into a world-class life sciences enterprise. For more information, please contact us at info@sansure.com.cn